Tuo Meng
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Ocular Diseases and Behçet’s Syndrome
Papers in
-
- Ocular Surface and Contact Lens 6
-
- Corneal Surgery and Treatments 6
- Corneal surgery and disorders 3
- Retinal Imaging and Analysis 1
- Co-authors
- Qingguo Xu (15 shared papers)Vineet Kulkarni (4 shared papers)Vikram Brar (1 shared paper)Haiping Hao (3 shared papers)Chujie Ding (1 shared paper)Qingran Li (1 shared paper)Wenyue Liu (1 shared paper)Wenjie Lu (1 shared paper)
- Journals
- Journal of Controlled Release (3 papers)Nanomedicine Nanotechnology Biology and Medicine (2 papers)International Journal of Pharmaceutics (2 papers)Drug Discovery Today (2 papers)Journal of Pharmacological Sciences (1 paper)
- Partner nations
- United StatesChinaPoland
In The Last Decade
Tuo Meng
19 papers receiving 647 citations
Peers
Comparison fields: 5 of 95
- Pharmaceutical Science 144
- Ophthalmology 118
- Radiology, Nuclear Medicine and Imaging 154
- Public Health, Environmental and Occupational Health 138
- Biomaterials 55
Countries citing papers authored by Tuo Meng
This map shows the geographic impact of Tuo Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuo Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuo Meng more than expected).
Fields of papers citing papers by Tuo Meng
This network shows the impact of papers produced by Tuo Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuo Meng. The network helps show where Tuo Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Tuo Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 111 | |
| 2 | 2019 | 105 | |
| 3 | 2017 | 91 | |
| 4 | 2019 | 68 | |
| 5 | 2023 | 51 | |
| 6 | 2019 | 40 | |
| 7 | 2020 | 36 | |
| 8 | 2016 | 31 | |
| 9 | 2019 | 31 | |
| 10 | 2020 | 18 | |
| 11 | 2017 | 17 | |
| 12 | 2023 | 16 | |
| 13 | 2021 | 11 | |
| 14 | 2021 | 7 | |
| 15 | 2024 | 6 | |
| 16 | 2023 | 5 | |
| 17 | 2024 | 4 | |
| 18 | 2020 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2020 | 0 |
About Tuo Meng
Tuo Meng is a scholar working on Public Health, Environmental and Occupational Health, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Ophthalmology and Pharmaceutical Science, having authored 20 papers that have together received 652 indexed citations. Recurring topics across this work include Corneal Surgery and Treatments (6 papers), Ocular Surface and Contact Lens (6 papers), Advanced Drug Delivery Systems (4 papers), Retinal Diseases and Treatments (3 papers), Corneal surgery and disorders (3 papers), Inhalation and Respiratory Drug Delivery (2 papers), Cystic Fibrosis Research Advances (2 papers) and Retinal Imaging and Analysis (1 paper). The work is most often cited by research in Pharmaceutical Science (144 citations), Ophthalmology (118 citations), Radiology, Nuclear Medicine and Imaging (154 citations), Public Health, Environmental and Occupational Health (138 citations) and Biomaterials (55 citations). Tuo Meng has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Qingguo Xu, Vineet Kulkarni, Vikram Brar, Haiping Hao, Chujie Ding, Qingran Li, Wenyue Liu, Wenjie Lu, Yumin Oh and Laura M. Ensign. Their work appears in journals such as Journal of Controlled Release, Nanomedicine Nanotechnology Biology and Medicine, International Journal of Pharmaceutics, Drug Discovery Today and Journal of Pharmacological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.